- Projects & figures
- News & Events
- Managing your project
- About ERC
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.
When Prof. Heino Falcke obtained an ERC grant to study and identify the sources of ultra-high energy cosmic rays, back in 2008, he could not imagine that his research would provide an important clue to better understand lightning and thunderclouds much closer to us. His team indeed realized that cosmic rays, originating in outer space and striking the Earth from all directions, can provide a near instantaneous 'picture' of the electric fields in clouds. The unexpected finding, to be published this week in Physical Review Letters, is the result of a fruitful collaboration between astronomers, particle physicists and geophysicists. The measurements were performed with the LOFAR radio telescope, located in the Netherlands, and partly funded by the ERC.
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and over will reach 16% of the global population. Medical science has an ever-growing arsenal of drugs it can use to treat an increasing range of conditions. Yet, these drugs are not acting as effectively as their potential promises. Dr. Armağan Koçer and her research team at the University of Groningen (The Netherlands) are using their ERC funding to tackle the following puzzle: how can we develop methods of drug delivery that are as revolutionary as the medicine they contain?